5,12-Naphthacenedione, 8-acetyl-10-[[3-[[(S)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-
-
![5,12-Naphthacenedione, 8-acetyl-10-[[3-[[(S)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)- structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/3e8e0bcb464f41509a39e65f3537ec5e.png "5,12-Naphthacenedione, 8-acetyl-10-[[3-[[(S)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-")
5,12-Naphthacenedione, 8-acetyl-10-[[3-[[(S)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-
structure -
-
CAS No:
66900-32-1
-
Formula:
C33H40N2O11
-
Chemical Name:
5,12-Naphthacenedione, 8-acetyl-10-[[3-[[(S)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-
-
Synonyms:
5,12-Naphthacenedione,8-acetyl-10-[[3-[[(S)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,(8S-cis)-;L-Leucyldaunorubicin;N-L-Leucyl-daunorubicin;NSC 311356
-
CAS No:
5,12-Naphthacenedione, 8-acetyl-10-[[3-[[(S)-2-amino-4-methyl-1-oxopentyl]amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)- Basic Attributes
640.7 g/mol
640.68
Computed Properties
Molecular Weight:640.7
XLogP3:2.9
Hydrogen Bond Donor Count:6
Hydrogen Bond Acceptor Count:12
Rotatable Bond Count:8
Exact Mass:640.26321010
Monoisotopic Mass:640.26321010
Topological Polar Surface Area:215
Heavy Atom Count:46
Complexity:1180
Defined Atom Stereocenter Count:6
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
5,12-Naphthacenedione, 8-acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-[3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-
50935-05-2
-
5,12-Naphthacenedione, 9-ethyl-7,8,9,10-tetrahydro-6,9,11-trihydroxy-7-[[2,3,6-trideoxy-3-(4-morpholinyl)-α-L-lyxo-hexopyranosyl]oxy]-, (7S,9S)-
132098-65-8
-
5,12-Naphthacenedione, 8-acetyl-10-[[3-[bis-(phenylmethyl)amino]-2,3,6-trideoxy-.α.-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-
70878-51-2
-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-4,6,9,10-tetrahydroxy-1,8-dimethoxy-9-methyl-7-[[2,3,6-trideoxy-3-(dimethylamino)-3-C-methylhexopyranosyl]oxy]- Formula
205752-47-2
-
5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- Formula
67324-99-6
-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-β-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI) Formula
57819-80-4
-
5,12-Naphthacenedione, 8-ethyl-7,8,9,10-tetrahydro-1,6,7,8,11-pentahydroxy-10-[[2,3,6-trideoxy-3-(4-morpholinyl)hexopyranosyl]oxy]-, hydrochloride (1:1), (7R,8R,10S)- Structure
131722-57-1
-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(diethylamino)-.α.-L-lyxo-hexopyranosyl]oxy]-, hydrochloride, (8S-cis)- Structure
70844-09-6
-
What is 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[(N-L-leucyl-L-alanyl)amino]-α-L-xylo-hexopyranosyl]oxy]-, monohydrochloride, (8S-cis)-
74853-79-5
-
What is 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(1-hydroxyethyl)-10-[[2,3,6-trideoxy-3-(formylamino)-α-L-lyxo-hexopyranosyl]oxy]-, (8S-cis)-
76634-96-3
Request for Quotation